Alphatec HoldingsATEC
ATEC
About: Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others.
Employees: 867
0
Funds holding %
of 7,419 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
190% more call options, than puts
Call options by funds: $18M | Put options by funds: $6.22M
69% more capital invested
Capital invested by funds: $461M [Q3] → $777M (+$316M) [Q4]
48% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 31
24% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 66
6% more funds holding
Funds holding: 214 [Q3] → 227 (+13) [Q4]
0.65% more ownership
Funds ownership: 59.06% [Q3] → 59.71% (+0.65%) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$13
22%
upside
Avg. target
$17.50
64%
upside
High target
$21
97%
upside
4 analyst ratings
4 positive
100%
0 neutral
0%
0 negative
0%
HC Wainwright & Co. Sean Lee 45% 1-year accuracy 13 / 29 met price target | 88%upside $20 | Buy Reiterated | 14 Apr 2025 |
Piper Sandler Matt O'Brien 32% 1-year accuracy 16 / 50 met price target | 22%upside $13 | Overweight Maintained | 27 Feb 2025 |
Needham David Saxon 28% 1-year accuracy 18 / 65 met price target | 50%upside $16 | Buy Reiterated | 27 Feb 2025 |
Barclays Matt Miksic 44% 1-year accuracy 18 / 41 met price target | 97%upside $21 | Overweight Maintained | 22 Jan 2025 |
Financial journalist opinion
Neutral
Business Wire
7 hours ago
ATEC Launches PTP™ Corpectomy, The Next Evolution of Lateral Approach Surgery
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the commercial launch of its Prone TransPsoas (PTP™) Corpectomy system. This milestone marks the continued evolution of ATEC's PTP surgical approach, expanding its capabilities to include deformity and corpectomy procedures for complex pathologies of the thoracolumbar spine. “PTP Corpectomy represents a signific.
Positive
Seeking Alpha
1 month ago
Alphatec Holdings: Business Has Reached An Inflection Point - Buy The Dip
In recent years, Alphatec Holdings or "ATEC" has outperformed sales expectations on a regular basis and successfully taken share in the $8 billion U.S. spinal disorder treatment market. The company continues to benefit from M&A-related disruptions at key competitors, which has created opportunities for ATEC to grab additional market share. Following years of elevated cash usage, the company managed to generate free cash flow in the final quarter of 2024.
Neutral
Business Wire
1 month ago
ATEC Prices Upsized $350.0 Million Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced the pricing of its offering of $350,000,000 aggregate principal amount of 0.75% convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The offering size was increased from t.
Neutral
Business Wire
1 month ago
ATEC Announces Proposed Convertible Senior Notes Offering
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced its intention to offer, subject to market and other conditions, $300,000,000 aggregate principal amount of convertible senior notes due 2030 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). ATEC also e.
Neutral
Seeking Alpha
1 month ago
Alphatec Holdings, Inc. (ATEC) Q4 2024 Earnings Call Transcript
Alphatec Holdings, Inc. (NASDAQ:ATEC ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Pat Miles - Chairman and CEO Todd Koning - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Vik Chopra - Wells Fargo Eric Anderson - TD Cowen Phillip Dantoin - Piper Sandler Matt Miksic - Barclays Caitlin Cronin - Canaccord Genuity Jason Wittes - ROTH David Saxon - Needham Kallum Titchmarsh - Morgan Stanley Operator Good afternoon, everyone, and welcome to the webcast of ATEC's Fourth Quarter Financial Results. We would like to remind everyone that participants on the call will make forward-looking statements.
Negative
Zacks Investment Research
1 month ago
Alphatec (ATEC) Reports Q4 Loss, Tops Revenue Estimates
Alphatec (ATEC) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.37 per share a year ago.
Neutral
Business Wire
1 month ago
ATEC Reports Fourth Quarter and Full Year 2024 Financial Results
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and year ended December 31, 2024, and business highlights. Fourth Quarter and Full Year 2024 Financial Results Quarter Ended December 31, 2024 Year Ended December 31, 2024 Total revenue $177 million $612 million GAAP gross margin 69% 69% Non-GAAP gross margin 70% 70% Operating e.
Neutral
Business Wire
1 month ago
ATEC to Participate in Upcoming Conferences
CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The Canaccord Genuity Musculoskeletal Conference in San Diego, CA, on March 10 2025, with a fireside chat at 10:30am PT The Barclays Global Healthcare Conference in Miami, FL, on March 11, 2025, with a fireside chat at 3:00pm ET If available.
Positive
Zacks Investment Research
3 months ago
Alphatec (ATEC) Moves 9.1% Higher: Will This Strength Last?
Alphatec (ATEC) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Positive
Zacks Investment Research
3 months ago
Wall Street Analysts Predict a 73.42% Upside in Alphatec (ATEC): Here's What You Should Know
The consensus price target hints at a 73.4% upside potential for Alphatec (ATEC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Charts implemented using Lightweight Charts™